Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 9Unknown 5Recruiting 4Active not recruiting 3Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gynecologic 1

Conditions

Uterine Cervical Neoplasms 133Ovarian Neoplasms 112Endometrial Neoplasms 83Uterine Cervical Dysplasia 19Papillomavirus Infections 17Breast Neoplasms 16Fallopian Tube Neoplasms 15Colorectal Neoplasms 14Carcinoma, Ovarian Epithelial 14Neoplasms 12Carcinoma, Non-Small-Cell Lung 12Vulvar Neoplasms 10Prostatic Neoplasms 10Neoplasm Metastasis 10Recurrence 9Endometrial Hyperplasia 9Cervical Cancer Screening 9Acquired Immunodeficiency Syndrome 8Uterine Neoplasms 7Stomach Neoplasms 7Squamous Intraepithelial Lesions 6Pancreatic Neoplasms 6Locally Advanced Cervical Cancer 6Head and Neck Neoplasms 6Anus Neoplasms 6Vaginal Neoplasms 5Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Pelvic Neoplasms 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Sarcoma, Synovial × Gynecologic × Clear all
NCT06748872 2024-12-27

EPITOME-1015-I

Medigene AG

Phase 1 Not yet recruiting
55 enrolled
GynecologicSarcoma

Carcinoma, Ovarian Epithelial, Sarcoma, Sarcoma, Synovial, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡